Takeda’s HYQVIA reduces CIDP relapse rates, Phase 3 trial reveals

Pallavi Madhiraju- June 22, 2023 0

Takeda Pharmaceutical Company has disclosed successful outcomes from its critical Phase 3 ADVANCE-CIDP 1 trial, focused on evaluating HYQVIA as a maintenance therapy for adults ... Read More

Medicinal Uses of the Enzymes Hemicellulase, Hyaluronidase and Lysozyme

pharmanewsdaily- December 9, 2013 0

Importance of the Enzyme Hemicellulase Hemicellulase is a complex enzyme which is necessary for hydrolysing cellulose and various hemicellulosic materials like gums and plant fibres. ... Read More